What Is The Size Of Global 3d Bioprinting Industry?
Global 3D Bioprinting market is growing at a CAGR of ~% in 2017-2022 and is expected to reach ~USD 5 Bn by 2028.
The 3D Bioprinting Market is largely driven by rapidly utilizing 3D bioprinting goods and technology in process of finding and developing new drugs.
Due to uncontrollable processing parameters and different materials, the additive manufacturing method’s accuracy varies between machines. A few monitoring techniques are available to assist producers in fulfilling their unique requirements by correcting these modifications. It has been challenging to create intricate and precise mathematical models using additive manufacturing, which acts as a major challenge for the market.
The market was positively impacted by the COVID-19 pandemic as various 3D Bioprinting communities are responding to the worldwide crises by offering their respective skills to ease the burden on the supply chain and governments. As the cases of COVID-19 are increasing day by day, there has been a shortage of materials for medical professionals as well as for the general public.
One of the biggest issues is the lack of availability of test kits for COVID-19. Hence, various 3D bioprinting companies are manufacturing 3D printers and related software on a large scale.
To learn more about this report Download a Free Sample Report
Global 3d Bioprinting Market By Component
The Global 3D Bioprinting market is segmented by Component into 3D Bioprinters and Bioinks.
The 3D bioprinters segment held the largest market share in the global 3D bioprinting market in 2022, owing to the growing demand for 3D bioprinting due to the widespread use of pharmaceutical pills to treat a variety of chronic conditions.
Bioprinting is a form of additive manufacturing that uses biomaterials instead of traditional metals and plastics to create 3D tissues.
3D bioprinters use three-dimensional technology in combination with biocompatible materials to replicate body parts. It is used for bioprinting of tissue, bone, organs, blood vessels tissue, and biomedical parts.
Global 3d Bioprinting Market By Material
The Global 3D Bioprinting market is segmented by Material into Living Cells, Hydrogels, Extracellular Matrices and Others.
The living cells segment held the largest market share in the global 3D bioprinting market in 2022, owing to rising demand from the pharmaceutical industry.
Using living cells as bio-inks, the inkjet technology allows for the printing of complex organs and tissues on culture substrates.
Living tissues and organs can be printed in three dimensions by layering living cells.
There is growing usage of living cells in regenerative medicine and stem cell research.
Global 3d Bioprinting Market By Application
The Global 3D Bioprinting market is segmented by Application into Research Application and Clinical Application.
The clinical application segment held the largest market share in the global 3D bioprinting market in 2022, owing to utilization of bioprinting technology in clinical trials of various diseases.
Bioprinting saves time in clinical trials and, thus, is being increasingly used for drug discovery. Biopharmaceutical companies are collaborating with market players to test their drugs.
Visit this Link: – Request for custom report
Key Topics Covered in the Report
- Snapshot of Global 3D Bioprinting Market
- Industry Value Chain and Ecosystem Analysis
- Market size and Segmentation of the Global 3D Bioprinting Market
- Historic Growth of Overall Global 3D Bioprinting Market and Segments
- Competition Scenario of the Market and Key Developments of Competitors
- Porter’s 5 Forces Analysis of Global 3D Bioprinting Industry
- Overview, Product Offerings, Strengths, & Weaknesses of Key Competitors
- Covid-19 Impact on the Overall Global 3D Bioprinting Market
- Future Market Forecast and Growth Rates of the Global 3D Bioprinting Market and Segments
- Analysis of Global 3D Bioprinting Market
- Major Production/Supply and Consumption/Demand Hubs within Each Region
- Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments
- Overview of Notable Emerging Competitor Companies within Each Region
Notable Key Players Mentioned in the Report
- Organovo Holdings, Inc.
- Inventia Life Science
- Poietis
- VIVAX BIO, LLC
- CYFUSE BIOMEDICAL K.K.
- 3D Bioprinting Solutions
- CELLINK
- BICO – THE BIO CONVERGENCE COMPANY
- CollPlant Biotechnologies Ltd.
- Aspect Biosystems Ltd.
Request free 30 minutes analyst call
Notable Emerging Companies Mentioned in the Report
- Organovo
- Prellis Biologics
- Pandorum Technologies
- Regenovo Biotechnology
Key Target Audience – Organizations and Entities Who Can Benefit by Subscribing This Report
- 3D Bioprinting Manufacturers
- 3D Bioprinting Suppliers
- 3D Bioprinters Manufacturers
- Bioinks Manufacturers
- Living Cells Suppliers
- Hydrogels Suppliers
- Extracellular Matrices Suppliers
- 3D Bioprinting Distributors
- Emerging and Startup Companies in 3D Bioprinting
- Different Types of 3D Bioprinting Manufacturing Hubs
- Government Departments of Healthcare
- Government Departments of Pharmaceuticals
- Ministries and Departments of Bio-based Materials
- Importers and Distributors of 3D Bioprinting
Period Captured in the Report
- Historical Period: 2017-2021
- Forecast Period: 2022E-2028F
For More Insights On Market Intelligence, Refer To The Link Below: –
